Literature DB >> 34055343

Mapping of predictors of the disengagement of the descending inhibitory pain modulation system in fibromyalgia: an exploratory study.

Matheus Dorigatti Soldatelli1,2,3, Timo Siepmann2,4, Ben Min-Woo Illigens2,5, Vinicius Souza Dos Santos3, Iraci Lucena da S Torres1,6, Felipe Fregni5, Wolnei Caumo1,3,6,7.   

Abstract

BACKGROUND: The main symptoms of fibromyalgia comprise diffuse pain, disability, depressive symptoms, catastrophizing, sleep disruption and fatigue, associated with dysfunction of the descending pain-modulating system (DPMS).
OBJECTIVES: We aimed to identify patterns of main symptoms of fibromyalgia and neuroplasticity biomarkers (i.e. brain-derived neurotrophic factor (BDNF) and S100B protein) in non-responders to the conditioned pain modulation task (CPM-task) induced by immersion of hand in cold water (0-1°C). Furthermore, we evaluated if these patterns predict responsiveness to CPM-task.
METHODS: This cross-sectional study included 117 women with fibromyalgia ((n = 60) non-responders and (n = 57) responders), with age ranging from 30 to 65 years old. We analysed changes in numerical pain scale (NPS-10) during the CPM-task using a standardized protocol.
RESULTS: A hierarchical multivariate logistic regression analysis was used to construct a propensity score-adjusted index to identify non-responders compared to responders to CPM-task. The following variables were retained in the models: analgesic use four or more times per week, heat pain threshold (HPT), poor sleep quality, pain catastrophizing, serum levels of BDNF, number of psychiatric diagnoses and the impact of symptoms of fibromyalgia on quality of life. Receiver operator characteristics (ROC) analysis showed non-responders can be discriminated from responders by a composite index of more frequent symptoms of fibromyalgia and neuroplasticity markers (area under the curve (AUC) = 0.83, sensitivity = 100% and specificity = 98%).
CONCLUSION: Patterns of fibromyalgia symptoms and neuroplasticity markers may be helpful to predict responsiveness to the CPM-task which might help personalize treatment and thereby contribute to the care of patients with fibromyalgia. © The British Pain Society 2020.

Entities:  

Keywords:  Catastrophizing; S100B; brain-derived neurotrophic factor; chronic pain; conditioned pain modulation-task

Year:  2020        PMID: 34055343      PMCID: PMC8138619          DOI: 10.1177/2049463720920760

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  67 in total

1.  Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain.

Authors:  Karin B Jensen; Eva Kosek; Frank Petzke; Serena Carville; Peter Fransson; Hanke Marcus; Steven C R Williams; Ernest Choy; Thorsten Giesecke; Yves Mainguy; Richard Gracely; Martin Ingvar
Journal:  Pain       Date:  2009-05-01       Impact factor: 6.961

Review 2.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

3.  Risk factors for postoperative anxiety in adults.

Authors:  W Caumo; A P Schmidt; C N Schneider; J Bergmann; C W Iwamoto; L C Adamatti; D Bandeira; M B Ferreira
Journal:  Anaesthesia       Date:  2001-08       Impact factor: 6.955

Review 4.  Culture, science and the changing nature of fibromyalgia.

Authors:  Frederick Wolfe; Brian Walitt
Journal:  Nat Rev Rheumatol       Date:  2013-07-02       Impact factor: 20.543

Review 5.  Bad news from the brain: descending 5-HT pathways that control spinal pain processing.

Authors:  Rie Suzuki; Lars J Rygh; Anthony H Dickenson
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

6.  Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample.

Authors:  Marcio Henrique Gomes-Oliveira; Clarice Gorenstein; Francisco Lotufo Neto; Laura Helena Andrade; Yuan Pang Wang
Journal:  Braz J Psychiatry       Date:  2012-12       Impact factor: 2.697

7.  Sleep continuity and architecture: associations with pain-inhibitory processes in patients with temporomandibular joint disorder.

Authors:  R R Edwards; E Grace; S Peterson; B Klick; J A Haythornthwaite; M T Smith
Journal:  Eur J Pain       Date:  2009-01-24       Impact factor: 3.931

8.  Poor Illness Perceptions Are a Risk Factor for Depressive and Anxious Symptomatology in Fibromyalgia Syndrome: A Longitudinal Cohort Study.

Authors:  Eric W de Heer; Johanna E Vriezekolk; Christina M van der Feltz-Cornelis
Journal:  Front Psychiatry       Date:  2017-11-01       Impact factor: 4.157

Review 9.  Serum S100B represents a new biomarker for mood disorders.

Authors:  Matthias L Schroeter; Julia Sacher; Johann Steiner; Peter Schoenknecht; Karsten Mueller
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

10.  The association between pain and sleep in fibromyalgia.

Authors:  Buse Keskindag; Meryem Karaaziz
Journal:  Saudi Med J       Date:  2017-05       Impact factor: 1.484

View more
  3 in total

1.  Algometry for the assessment of central sensitisation to pain in fibromyalgia patients: a systematic review.

Authors:  Pablo de la Coba; Casandra I Montoro; Gustavo A Reyes Del Paso; Carmen M Galvez-Sánchez
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

2.  Hyper-connectivity between the left motor cortex and prefrontal cortex is associated with the severity of dysfunction of the descending pain modulatory system in fibromyalgia.

Authors:  Álvaro de Oliveira Franco; Camila Fernanda da Silveira Alves; Paul Vicuña; Janete Bandeira; Maria Adelia de Aratanha; Iraci L S Torres; Felipe Fregni; Wolnei Caumo
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

3.  Association between descending pain modulatory system and cognitive impairment in fibromyalgia: A cross-sectional exploratory study.

Authors:  Paul Vicuña Serrano; Maxciel Zortea; Rael Lopes Alves; Gerardo Beltran; Cibely Bavaresco Deliberali; Amanda Maule; Iraci L S Torres; Felipe Fregni; Wolnei Caumo
Journal:  Front Behav Neurosci       Date:  2022-09-29       Impact factor: 3.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.